ReviewThe oncologist2022
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
James Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papertrialcites it
ReviewThe oncologist2022
James Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.